228 results
8-K
EX-10.1
WINT
Windtree Therapeutics Inc
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
. The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks
8-K
EX-1.1
WINT
Windtree Therapeutics Inc
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
on the number and aggregate sales price of Shares issued and sold under this Agreement shall be the sole responsibility of the Company and that the Manager … financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company
424B5
WINT
Windtree Therapeutics Inc
9 Nov 23
Prospectus supplement for primary offering
4:11pm
prospectus and any free writing prospectus prepared by or on behalf of us or to which we have referred you. We and Ladenburg take no responsibility … no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We will not make
8-K
eit57416wk
28 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-4.1
qnpdb6dkpxqpi kki56w
24 Apr 23
Entry into a Material Definitive Agreement
4:40pm
8-K
EX-1.1
5obrhs
24 Apr 23
Entry into a Material Definitive Agreement
4:40pm
424B4
fs4cn4ggwh
20 Apr 23
Prospectus supplement with pricing info
6:03pm